The connection between people with genetically defined diseases and our therapies may be the most important connection we make. That’s why we pledge to set prices for our medicines that allow us to reach as many people as possible – ensuring wide access to our medicines for patients today and continued investment in innovation for the patients of tomorrow.
Regardless of the price point of our medicines, we recognize that some people, especially the uninsured, will need help funding their therapy. And cost isn’t the only barrier when it comes to accessing therapies. To put medicine within reach, we are committed to offering patient assistance programs tailored to address the needs of each patient community we serve.
We’ve developed an access and pricing philosophy that articulates our commitment to access, as well as principles that guide our decision-making and enable us to put this philosophy into action.